Peer review reports
From: Dolutegravir-associated resistance mutations after first-line treatment failure in Brazil
Original Submission | ||
---|---|---|
26 Sep 2022 | Submitted | Original manuscript |
22 Dec 2022 | Reviewed | Reviewer Report |
2 Jan 2023 | Reviewed | Reviewer Report |
4 Jan 2023 | Reviewed | Reviewer Report |
28 Feb 2023 | Author responded | Author comments - Ricardo Sobhie Diaz |
Resubmission - Version 2 | ||
28 Feb 2023 | Submitted | Manuscript version 2 |
31 Mar 2023 | Reviewed | Reviewer Report |
4 Apr 2023 | Reviewed | Reviewer Report |
22 Apr 2023 | Author responded | Author comments - Ricardo Sobhie Diaz |
Resubmission - Version 3 | ||
22 Apr 2023 | Submitted | Manuscript version 3 |
Publishing | ||
27 Apr 2023 | Editorially accepted | |
24 May 2023 | Article published | 10.1186/s12879-023-08288-8 |